Literature DB >> 25522989

Functionality of HDL: antioxidation and detoxifying effects.

Helen Karlsson1, Anatol Kontush, Richard W James.   

Abstract

High-density lipoproteins (HDL) are complexes of multiple talents, some of which have only recently been recognised but all of which are under active investigation. Clinical interest initially arose from their amply demonstrated role in atherosclerotic disease with their consequent designation as a major cardiovascular disease (CVD) risk factor. However, interest is no longer confined to vascular tissues, with the reports of impacts of the lipoprotein on pancreatic, renal and nervous tissues, amongst other possible targets. The ever-widening scope of HDL talents also encompasses environmental hazards, including infectious agents and environmental toxins. In almost all cases, HDL would appear to have a beneficial impact on health. It raises the intriguing question of whether these various talents emanate from a basic ancestral function to protect the cell.The following chapter will illustrate and review our current understanding of some of the functions attributed to HDL. The first section will look at the antioxidative functions of HDL and possible mechanisms that are involved. The second section will focus specifically on paraoxonase-1 (PON1), which appears to bridge the divide between the two HDL functions discussed herein. This will lead into the final section dealing with HDL as a detoxifying agent protecting against exposure to environmental pathogens and other toxins.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25522989     DOI: 10.1007/978-3-319-09665-0_5

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  17 in total

1.  HDL and Oxidation.

Authors:  Qi Zhang; Zongzhe Jiang; Yong Xu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses.

Authors:  Vilma Aho; Hanna M Ollila; Erkki Kronholm; Isabel Bondia-Pons; Pasi Soininen; Antti J Kangas; Mika Hilvo; Ilkka Seppälä; Johannes Kettunen; Mervi Oikonen; Emma Raitoharju; Tuulia Hyötyläinen; Mika Kähönen; Jorma S A Viikari; Mikko Härmä; Mikael Sallinen; Vesa M Olkkonen; Harri Alenius; Matti Jauhiainen; Tiina Paunio; Terho Lehtimäki; Veikko Salomaa; Matej Orešič; Olli T Raitakari; Mika Ala-Korpela; Tarja Porkka-Heiskanen
Journal:  Sci Rep       Date:  2016-04-22       Impact factor: 4.379

3.  Feasibility of a plasma bioassay to assess oxidative protection of low-density lipoproteins by high-density lipoproteins.

Authors:  Debi K Swertfeger; Sandra Rebholz; Hailong Li; Amy S Shah; William Sean Davidson; Long J Lu
Journal:  J Clin Lipidol       Date:  2018-08-27       Impact factor: 4.766

4.  Persistently high psychological well-being predicts better HDL cholesterol and triglyceride levels: findings from the midlife in the U.S. (MIDUS) longitudinal study.

Authors:  Barry T Radler; Attilio Rigotti; Carol D Ryff
Journal:  Lipids Health Dis       Date:  2018-01-03       Impact factor: 3.876

Review 5.  Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit.

Authors:  Fernando Brites; Maximiliano Martin; Isabelle Guillas; Anatol Kontush
Journal:  BBA Clin       Date:  2017-08-19

6.  AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE-/- mice.

Authors:  Ang Ma; Jing Wang; Liu Yang; Yuanyuan An; Haibo Zhu
Journal:  J Lipid Res       Date:  2017-06-13       Impact factor: 5.922

7.  Feedback inhibition of CREB signaling by p38 MAPK contributes to the negative regulation of steroidogenesis.

Authors:  Jiaxin Li; Qian Zhou; Zhuang Ma; Meina Wang; Wen-Jun Shen; Salman Azhar; Zhigang Guo; Zhigang Hu
Journal:  Reprod Biol Endocrinol       Date:  2017-03-16       Impact factor: 5.211

Review 8.  Antioxidant properties of HDL.

Authors:  Handrean Soran; Jonathan D Schofield; Paul N Durrington
Journal:  Front Pharmacol       Date:  2015-10-16       Impact factor: 5.810

9.  Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.

Authors:  Karen Alejandra Méndez-Lara; David Santos; Núria Farré; Sheila Ruiz-Nogales; Sergi Leánez; José Luis Sánchez-Quesada; Edgar Zapico; Enrique Lerma; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Jesús María Martín-Campos; Josep Julve; Olga Pol
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

Review 10.  Paraoxonases Activities and Polymorphisms in Elderly and Old-Age Diseases: An Overview.

Authors:  Débora Levy; Cadiele Oliana Reichert; Sérgio Paulo Bydlowski
Journal:  Antioxidants (Basel)       Date:  2019-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.